Textbook on Development and Evaluation of Liquid Dosage Form

Gulfisha Shaikh

ISBN 10: 6203862150 / ISBN 13: 9786203862157

Published by LAP LAMBERT Academic Publishing, 2021

About this Item

nach der Bestellung gedruckt Neuware - Printed after ordering - Developing a new drug delivery technologies and utilizing them in product development is critical for pharmaceutical industries to isurvive, regardless of their size. As a drug nears the end of its patent life, it is common for pharmaceutical manufacturers to develop a given drug entity in a new and improved dosage form. A new dosage form allows a manufacturer to extend market exclusivity, unique product differentiation, value-added product line extension, and extend patent protection, while offering its patient population a more convenient dosage form. This leads to increased revenue, while also targeting under-served and under-treated patient ipopulations. Marketers build a better brand and company image when they offer a unique easier-to-take form that satisfies the need of an underserved patient population.

Seller Inventory # 9786203862157

Bibliographic Details

• Title: Textbook on Development and Evaluation of Liquid Dosage Form
• Publisher: LAP LAMBERT Academic Publishing
• Publication Date: 2021
• Language: English
• ISBN 10: 6203862150
• ISBN 13: 9786203862157
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 220W x 150H x 5D millimeters 220 millimeters width by 150 millimeters height by 5 millimeters depth
• Weight: 119 grams

About this title

Synopsis

Developing a new drug delivery technologies and utilizing them in product development is critical for pharmaceutical industries to isurvive, regardless of their size. As a drug nears the end of its patent life, it is common for pharmaceutical manufacturers to develop a given drug entity in a new and improved dosage form. A new dosage form allows a manufacturer to extend market exclusivity, unique product differentiation, value-added product line extension, and extend patent protection, while offering its patient population a more convenient dosage form. This leads to increased revenue, while also targeting under-served and under-treated patient ipopulations. Marketers build a better brand and company image when they offer a unique easier-to-take form that satisfies the need of an underserved patient population.